PACKAGE LEAFLET: INFORMATION FOR THE USER. Glucose Intravenous Infusion BP 10% w/v solution for infusion Glucose (as glucose monohydrate)

Similar documents
Sodium Chloride 0.9% w/v Intravenous Infusion BP Solution for Infusion Sodium chloride

PACKAGE LEAFLET: INFORMATION FOR THE USER. Nutriflex plus Solution for Infusion Amino acids / Glucose / Electrolytes

PACKAGE LEAFLET: INFORMATION FOR THE USER. Nutriflex peri Solution for Infusion. Amino acids / Glucose / Electrolytes

2. What you need to know before you use Compound Sodium Lactate

Potassium Chloride 0.3% w/v and Sodium Chloride 0.9% w/v Solution for Infusion Potassium chloride and sodium chloride

Package leaflet: Information for the patient. Heparin Sodium BP 1000 IU/L in 0.9% w/v Sodium Chloride IV Infusion. Active substance: Heparin Sodium

Package leaflet: Information for the user. Aminoven 5% Solution for infusion Aminoven 10% Solution for infusion Aminoven 15% Solution for infusion

Hartmann s Solution. For Infusion

Package leaflet: Information for the user. Lidocaine Hydrochloride 1% w/v Solution for Injection Lidocaine Hydrochloride

Package leaflet: Information for the user

1. What Octostim Nasal Spray is and what it is used for

Package leaflet: Information for the user. Elaprase 2 mg/ml concentrate for solution for infusion idursulfase

Package leaflet: Information for the user. multibic potassium-free solution for haemodialysis/haemofiltration

2. What you need to know before you take DDAVP/Desmopressin Tablets

Package leaflet: Information for the patient. Selenium 10 micrograms/ml concentrate for solution for infusion. Sodium selenite

Package leaflet: Information for the patient. Tranexamic Acid 100 mg/ml, Solution for Injection tranexamic acid

1. What Faslodex is and what it is used for

Package leaflet: Information for the user

The medicines you are using mixed with Water for injections may interact with each other.

Package leaflet: Information for the user. Portrazza 800 mg concentrate for solution for infusion necitumumab

Havrix Monodose Vaccine Hepatitis A Vaccine (Inactivated, adsorbed) ELISA Units/1 ml Suspension for Injection in a pre-filled syringe

Package leaflet: Information for the patient. Konakion MM Ampoules 10mg/ml solution for injection and oral solution Phytomenadione (vitamin K 1 )

Package leaflet: Information for the user Zinforo 600 mg powder for concentrate for solution for infusion Ceftaroline fosamil

Package leaflet: Information for the user. Bridion 100 mg/ml solution for injection sugammadex

PACKAGE LEAFLET: INFORMATION FOR THE USER. Pneumococcal Polysaccharide Vaccine

THORENS I.U. /2.5 ml oral solution. Cholecalciferol (vitamin D 3 )

Package leaflet: Information for the patient

Package leaflet: Information for the patient. Zerbaxa 1 g / 0.5 g powder for concentrate for solution for infusion ceftolozane / tazobactam

Package leaflet: Information for the patient. ERWINASE 10,000 Units, Powder for solution for injection

PACKAGE LEAFLET: INFORMATION FOR THE USER RENNIE DUAL ACTION TABLETS. Calcium carbonate, Magnesium carbonate, Alginic acid Chewable tablets

Package leaflet: Information for the user. Poliomyelitis Vaccine (Inactivated) suspension for injection in pre-filled syringe

Package leaflet: Information for the user. ReoPro 2 mg/ml solution for injection or infusion. abciximab

Package leaflet: Information for the User

Package leaflet: Information for the patient

Package leaflet: Information for the patient

Package leaflet: Information for the patient. Histaclar 10 mg Film-coated Tablets loratadine

PACKAGE LEAFLET: INFORMATION FOR THE USER. Zoledronic Acid 4 mg/5 ml concentrate for solution for infusion. Zoledronic acid

LEUCOVORIN-TEVA 10 mg/ml CONCENTRATE FOR SOLUTION FOR INFUSION folinic acid as the calcium salt PACKAGE LEAFLET: INFORMATION FOR THE USER

Package leaflet: Information for the user. Resolor 1 mg film-coated tablets Resolor 2 mg film-coated tablets prucalopride

Package leaflet: Information for the User Clarityn 1 mg/ml syrup Loratadine

Zofran syrup contains a medicine called ondansetron. This belongs to a group of medicines called anti-emetics.

Package leaflet: Information for the user. Colecalciferol 3000 IU/ml Oral Solution (colecalciferol)

Package leaflet: Information for the user. Carmellose sodium

Echinaforce Hot Drink

Package leaflet: Information for the patient. SIRTURO 100 mg tablets Bedaquiline

1. What Ursofalk 250mg hard capsules are and what they are used for

Package leaflet: Information for the patient. Trasylol 10,000 KIU/ml solution for injection or infusion. Aprotinin

Package leaflet: Information for the patient. Olumiant 2 mg film-coated tablets Olumiant 4 mg film-coated tablets Baricitinib

Package leaflet: Information for the user Venofer 20 mg iron /ml Solution for injection or concentrate for solution for infusion Iron Sucrose

PACKAGE LEAFLET: INFORMATION FOR THE USER. Active substance: enoximone

Package Leaflet: Information for the user. LUMIGAN 0.3 mg/ml, eye drops, solution, in single-dose container Bimatoprost

Package leaflet: Information for the user 1% w/v Lidocaine Hydrochloride Injection BP Lidocaine Hydrochloride

Read all of this leaflet carefully before you start taking this medicine because it contains important information for you.

PACKAGE LEAFLET: INFORMATION FOR THE USER. EASOFEN MAX STRENGTH 400mg FILM-COATED TABLETS. Ibuprofen

Package leaflet: Information for the user

Package leaflet: Information for the user. <PRODUCT NAME> 10 g powder for oral solution in sachet Macrogol 4000

Package leaflet: Information for the user. Novastan 100 mg/ml concentrate for solution for infusion. argatroban monohydrate

Package leaflet: Information for the user. Exembol 1 mg/ml solution for infusion. argatroban monohydrate

Zofran tablets contain a medicine called ondansetron. This belongs to a group of medicines called anti-emetics.

Package leaflet: Information for the user. Irprestan 150 mg film-coated tablets. Irprestan 300 mg film-coated tablets irbesartan

Suspension for injection in pre-filled syringe Diphtheria, tetanus and pertussis (acellular component) vaccine (adsorbed, reduced antigen content)

PACKAGE LEAFLET: INFORMATION FOR THE USER. Bydureon 2 mg powder and solvent for prolonged-release suspension for injection in pre-filled pen exenatide

Ascorbic Acid. Dr. Scheffler Vitamin C effervescent tablets are used for the treatment of vitamin C deficiency diseases (e. g. scurvy).

Package leaflet: Information for the patient. NEGABAN 1g, powder for solution for injection or infusion Temocillin

PACKAGE LEAFLET: INFORMATION FOR THE USER. Zoledronic Acid IBIGEN 4 mg powder and solvent for solution for infusion Zoledronic acid

PACKAGE LEAFLET: INFORMATION FOR THE USER. ZADITEN 1 mg/5 ml Oral Solution. Ketotifen (as Ketotifen hydrogen fumarate)

Package leaflet: Information for the patient. Paracetamol 10 mg/ml solution for infusion. Paracetamol

Package leaflet: Information for the user. Tuberculin PPD RT23 "SSI" 2 T.U./0.1 ml, solution for injection Tuberculin PPD RT 23

PACKAGE LEAFLET: INFORMATION FOR THE USER. DUKORAL suspension and effervescent granules for oral suspension Cholera vaccine (inactivated, oral)

Package leaflet: Information for patient

Package leaflet: Information for the User Clarityn 10 mg tablets Loratadine

User Package Leaflet for Treosulfan 5 g Powder for Solution for Injection or Infusion

PACKAGE LEAFLET: INFORMATION FOR THE USER. Human Albumin Biotest 20%, solution for infusion Human albumin

PACKAGE LEAFLET: INFORMATION FOR THE USER. Tantum Verde orange-honey taste 3 mg lozenges Benzydamine Hydrochloride

Package leaflet: Information for the user. Methylthioninium chloride Proveblue 5 mg/ml solution for injection Methylthioninium chloride

Atrosan Devil s Claw film-coated tablets

Package leaflet: Information for the user. Cefixime ABR 100 mg/5 ml powder for oral suspension Cefixime

PACKAGE LEAFLET: INFORMATION FOR THE USER. SODIPHOS 22mEq / 10ml Concentrate for solution for infusion. Disodium phosphate dihydrate

Package leaflet: Information for the user. HEPATECT CP 50 IU/ml solution for infusion. Human hepatitis B immunoglobulin for intravenous administration

Package leaflet: Information for the patient. Calcium Folinate 15 mg Tablets calcium folinate

PACKAGE LEAFLET: INFORMATION FOR THE USER Paracodin 0.20% w/w Syrup (dihydrocodeine hydrogen tartrate)

Package leaflet: Information for the patient Tranexamic acid 100 mg/ml Solution for Injection tranexamic acid

Package leaflet: Information for the patient. Vertigon 8 mg Tablets Vertigon 16 mg Tablets (betahistine dihydrochloride)

Package leaflet: Information for the user. Ondansetron 4mg/5ml Syrup (ondansetron as ondansetron hydrochloride dihydrate)

PYRIDOSTIGMINE LIME TM 60MG TABLETS Pyridostigmine bromide

PACKAGE LEAFLET: INFORMATION FOR THE PATIENT

Package leaflet: Information for the user. Raxone 150 mg film-coated tablets idebenone

Package Leaflet : Information for the User. IOPIDINE 1%w/v eye drops solution (Apraclonidine Hydrochloride)

Package leaflet: Information for the user

Package Leaflet: Information for the user. Digestisan oral drops

1. What Betahistine dihydrochloride tablets is and what it is used for

Package leaflet: Information for the user. Cyanokit 5 g powder for solution for infusion hydroxocobalamin

Patient Leaflet : Information for the user Locoid Cream 0.1% w/w Hydrocortisone butyrate

Package Leaflet: Information for the User Zotron 4mg/2ml (ή 8mg/4ml) Solution for Injection or Infusion ondansetron

Package Leaflet: Information for the user

Package leaflet: Information for the patient. Metformin Actavis 500 mg and 850 mg filmcoated tablets. metformin hydrochloride

PACKAGE LEAFLET: INFORMATION FOR THE USER. Finasteride 5mg Film-coated Tablets. (Finasteride) This medicine is for use in men only

Package leaflet: Information for the patient

Transcription:

PACKAGE LEAFLET: INFORMATION FOR THE USER Glucose Intravenous Infusion BP 10% w/v solution for infusion Glucose (as glucose monohydrate) Read all of this leaflet carefully before you start using this medicine because it contains important information for you. Keep this leaflet. You may need to read it again. If you have any further questions, ask your doctor, pharmacist or nurse. This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their signs of illness are the same as yours. If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in this leaflet. What is in this leaflet 1. What Glucose Intravenous Infusion BP 10% w/v solution for infusion is and what it is used for 2. What you need to know before you receive Glucose Intravenous Infusion BP 10% w/v solution for infusion 3. How to use Glucose Intravenous Infusion BP 10% w/v solution for infusion 4. Possible side effects 5. How to store Glucose Intravenous Infusion BP 10% w/v solution for infusion 6. Contents of the pack and other information 1. WHAT GLUCOSE INTRAVENOUS INFUSION BP 10% W/V SOLUTION FOR INFUSION IS AND WHAT IT IS USED FOR Glucose Intravenous Infusion BP 10% w/v solution for infusion is a solution that contains glucose for administration in the form of a vein drip (intravenous infusion). You are given this medicine to provide you with carbohydrates if you are unable to eat and drink normally. You may also be given it in order to raise an abnormally low blood sugar level. The solution may also be used to dissolve or dilute medicines that are to be given to you by infusion. Glucose solutions can also be used to replace body fluids lost for example from bleeding, severe vomiting, severe diarrhoea etc. 2. WHAT YOU NEED TO KNOW BEFORE YOU RECEIVE GLUCOSE INTRAVENOUS INFUSION BP 10% W/V SOLUTION FOR INFUSION You will not receive Glucose Intravenous Infusion BP 10% w/v solution for infusion if you have too high blood sugar level (hyperglycaemia) that needs more than 6 units of insulin per hour to be controlled delirium tremens associated with severe fluid deficit severely impaired blood circulation, i.e. states of shock and circulatory collapse high levels of acidic substances in your blood (acidosis) too much water in your body water in your lungs severe kidney failure (severe renal insufficiency) where no dialysis facilities are available acute heart failure.

This container contains a significant volume of air. To avoid the risk of air embolism, this product must not be administered by pressure infusion. Warnings and precautions Talk to your doctor or nurse before using Glucose Intravenous Infusion BP 10% w/v solution for infusion You should not normally receive this medicine if you suffer or have recently suffered from stroke except your doctor considers it essential for your recovery. Your levels of blood sugar, fluids, electrolytes (particularly potassium) and acid-base balance will be checked to make sure that these are correct before and during infusion. For this purpose blood samples may be taken from you. If necessary, your blood sugar will be controlled by insulin administration. Before you receive this medicine any existing disorders of your body s fluid and salt content such as: too low potassium or sodium level in your blood (hypokalaemia, hyponatraemia) water deficiency and excessive losses of salts have to be corrected. Your doctor will consider very carefully whether this medicine is suitable for you if you have: diabetes or any other kind of carbohydrate intolerance high blood volume any kind of impairment of your metabolism (e.g. after operations or injuries, with too little oxygen in your tissues, or with some organ diseases) where your blood may become acidic abnormally high concentrated blood serum (high serum osmolarity) impairment of kidney, or heart function. Your doctor will take special care for you if your blood-brain barrier is damaged, because then this medicine may cause an increase of the pressure within your skull or the spinal cord. If signs of vein irritation or inflammation of the wall of a vein at the site of infusion occur, your doctor will consider changing the infusion site. Adequate supply of salts (in particular potassium, magnesium, phosphate) and vitamins (in particular vitamin -B 1 ) will be ensured. Children Special care will be taken when giving this medicine to children in the first and second year of life, because a sudden stop of high infusion rates can lead to very low blood sugar levels, especially in these children. Other medicines and Glucose Intravenous Infusion BP 10% w/v solution for infusion Tell your doctor if you are taking, have recently taken or might take any other medicines.your doctor will take care only to add drugs or additives to the solution that mix well with it. Packed red blood cells will not be added to this solution nor is it infused together with, immediately before or after blood through the same tubing. Pregnancy and breast-feeding If you are pregnant or breast-feeding, think you may be pregnant or are planning to have a baby, ask your doctor for advice before taking this medicine.

Your doctor will decide carefully whether or not you should receive this solution if you are pregnant or breastfeeding your child. Driving and using machines This medicine has no influence on the ability to drive and use machines. 3. HOW TO USE GLUCOSE INTRAVENOUS INFUSION BP 10% W/V SOLUTION FOR INFUSION The amount of Glucose Intravenous Infusion BP 10% w/v solution for infusion you will be given will be determined by your doctor, depending upon your condition. Dosage For adults and adolescents from 15 th year of life, the maximum amount is 40ml per kg body weight per day. The solution will be administered to you not faster than at a rate of 2.5 ml per kg body weight per hour. For children up to the 14 th year of life the maximum daily amount of this medicine will be determined according to the age the body weight, and the recommended total daily fluid intake. Method of administration The solution will be administered to you through a small tube inserted into a vein (by intravenous infusion). If you receive more Glucose Intravenous Infusion BP 10% w/v solution for infusion than you should It is unlikely that this occurs because your doctor will determine your daily doses. Overdose may result in too high levels of blood sugar, glucose losses in urine, abnormally high concentrated body fluids, fluid deficit, impaired consciousness or unconsciousness due to extremely high blood sugar or too concentrated body fluids, excess fluid in the body with increased skin tension, venous congestion (heaviness and swelling of legs), tissue swelling (possibly with water on the lungs or swelling of the brain), and abnormally high or low blood electrolyte levels. Extreme overdosing may also lead to accumulation of fat in the liver. If this occurs, your glucose infusion will be slowed down or stopped. Your doctor will decide on any further treatment you may need, e.g. administration of insulin, fluid or salts. If you have any further questions on the use of this medicine, ask your doctor, pharmacist, or nurse. 4. POSSIBLE SIDE EFFECTS Like all medicines, this medicine can cause side effects, although not everybody gets them. The following side effects may occur when glucose is administered as an infusion: Common: may affect up to 1 in 10 people Local reactions at the injection site such as pain, vein irritation or inflammation (phlebitis, thrombophlebitis).

Reporting of side effects If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via via HPRA Pharmacovigilance, Earlsfort Terrace, IRL - Dublin 2; Tel: +353 1 6764971; Fax: +353 1 6762517. Website: www.hpra.ie; e-mail: medsafety@hpra.ie. By reporting side effects you can help provide more information on the safety of this medicine. 5. HOW TO STORE GLUCOSE INTRAVENOUS INFUSION BP 10% W/V SOLUTION FOR INFUSION Keep this medicine out of the sight and reach of children. Do not use this medicine after the expiry date which is stated on the bottle and carton labels. The expiry date refers to the last day of that month. Do not use this medicine if the solution is not clear and colourless or almost colourless or if the bottle or its closure are damaged. Do not store above 25 C. 6. CONTENTS OF THE PACK AND OTHER INFORMATION What Glucose Intravenous Infusion BP 10% w/v solution for infusion contains The active substance is glucose monohydrate. Per litre this medicine contains 110 g of glucose monohydrate, equivalent to 100g of glucose. The other ingredient is water for injections. Energy 1675 kj/l 400 kcal/l Theoretical osmolarity 555 mosm/l Titration acidity (to ph 7.4) < 0.5 mmol/l ph 3.5 5.5 What Glucose Intravenous Infusion BP 10% w/v solution for infusion looks like and contents of the pack Glucose Intravenous Infusion BP 10% w/v solution for infusion is a solution for infusion (for administration by a vein drip). It is a clear, colourless or almost colourless solution of glucose monohydrate in water. It comes in colourless plastic (polyethylene) bottles containing 500 ml or 1000 ml, supplied in packs of 10 500 ml, 10 1000 ml Not all pack sizes may be marketed. Marketing Authorisation Holder and Manufacturer PA Holder:

B. Braun Medical Ltd., 3 Naas Road Industrial Park, Dublin 12, Ireland PA Number: PA 179/1/28 Manufacturer: B. Braun Melsungen AG Carl-Braun-Straße 1 34212 Melsungen Germany This leaflet was last approved in 07/2014. The following information is intended for healthcare professionals only: Method of administration Intravenous use. The solution can be infused via a large peripheral vein. If Glucose Intravenous Infusion BP 10% w/v solution for infusion is used as vehicle solution, the possibility of peripheral infusion depends on the characteristics of the mixture prepared. Special warnings and precautions for use Sudden discontinuation of high glucose infusion rates can lead to profound hypoglycaemia due to the accompanying high serum insulin concentrations. This applies especially to children less than 2 years of age, patients with diabetes mellitus and other disease states associated with impaired glucose homeostasis. In obvious cases the glucose infusion should be tapered off within the last 30 60 minutes of the infusion. As a precaution it is recommended that each individual patient be monitored for 30 minutes for hypoglycaemia on the first day of abrupt discontinuation of parenteral nutrition. Shelf life after first opening the container Administration should commence immediately after connecting the container to the giving set or infusion equipment. Incompatibilities Because of its acid ph, the solution may be incompatible with other medicinal products. Erythrocyte concentrates must not be suspended in glucose solutions because of the risk of pseudoagglutination. For full information on this product please refer to the SmPC of Glucose Intravenous Infusion BP 10% w/v solution for infusion.